# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001683168-20-002680
Filing Date
2020-08-13
Accepted
2020-08-13 17:05:13
Documents
73
Period of Report
2020-04-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-K | pharmacyte_10k-043020.htm | 10-K | 1317184
2 | LIST OF SUBSIDIARIES | pharmacyte_ex2101.htm | EX-21.1 | 2098
3 | CONSENT | pharmacyte_ex2301.htm | EX-23.1 | 2002
4 | CERTIFICATION | pharmacyte_ex3101.htm | EX-31.1 | 8438
5 | CERTIFICATION | pharmacyte_ex3102.htm | EX-31.2 | 8435
6 | CERTIFICATION | pharmacyte_ex3201.htm | EX-32.1 | 4018
7 | CERTIFICATION | pharmacyte_ex3202.htm | EX-32.2 | 4140
8 | GRAPHIC | image1.jpg | GRAPHIC | 25664
9 | GRAPHIC | image2.jpg | GRAPHIC | 23383
10 | GRAPHIC | image3.jpg | GRAPHIC | 2605
11 | GRAPHIC | image_001.jpg | GRAPHIC | 2380
| Complete submission text file | 0001683168-20-002680.txt |  | 4477100

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
12 | XBRL INSTANCE FILE | pmcb-20200430.xml | EX-101.INS | 689072
13 | XBRL SCHEMA FILE | pmcb-20200430.xsd | EX-101.SCH | 40473
14 | XBRL CALCULATION FILE | pmcb-20200430_cal.xml | EX-101.CAL | 48514
15 | XBRL DEFINITION FILE | pmcb-20200430_def.xml | EX-101.DEF | 165109
16 | XBRL LABEL FILE | pmcb-20200430_lab.xml | EX-101.LAB | 278674
17 | XBRL PRESENTATION FILE | pmcb-20200430_pre.xml | EX-101.PRE | 255715

Mailing Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653
Business Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653 (917) 595.2850
PharmaCyte Biotech, Inc. (Filer) CIK: 0001157075 (see all company filings)

EIN.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
Type: 10-K | Act: 34 | File No.: 333-68008 | Film No.: 201100150
SIC: 2836 Biological Products, (No Diagnostic Substances)